Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
3187 |
|
| Actual shortage: | 258 (8%) | |
| Anticipated shortage: | 1 (0%) | |
| Avoided shortage: | 10 (0%) | |
| Resolved: | 2918 (92%) | |
Discontinuation Reports |
435 |
|
| To be discontinued: | 2 (0%) | |
| Discontinued: | 410 (94%) | |
| Reversed: | 23 (5%) | |
Late reports |
482 (13%) |
|
Overdue reports |
11 (4%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-OLMESARTAN | 20MG | TABLET | Resolved | 2018-10-22 | 2020-06-11 | 65350 |
| TEVA-OLMESARTAN / HCTZ | 12.5MG 40MG | TABLET | Resolved | 2018-09-12 | 2020-06-11 | 61359 |
| TEVA-OLMESARTAN / HCTZ | 12.5MG 20MG | TABLET | Resolved | 2018-10-22 | 2020-06-11 | 65343 |
| TEVA-OLMESARTAN / HCTZ | 25MG 40MG | TABLET | Resolved | 2018-10-22 | 2020-06-11 | 65346 |
| ACT OLOPATADINE 0.1% | 0.1% | SOLUTION | Actual shortage | 2018-10-23 | 2018-10-23 | 65519 |
| ACT OLOPATADINE 0.2% | 0.2% | SOLUTION | Actual shortage | 2018-10-23 | 2018-10-23 | 65516 |
| TEVA-ONDANSETRON | 8MG | TABLET | Resolved | 2021-07-15 | 2023-04-28 | 142604 |
| TEVA-ONDANSETRON | 4MG | TABLET | Resolved | 2021-07-15 | 2023-04-28 | 142607 |
| ACT OXYCODONE CR | 5MG | TABLET (EXTENDED-RELEASE) | Resolved | 2017-03-17 | 2017-09-19 | 3366 |
| ACT OXYCODONE CR | 10MG | TABLET (EXTENDED-RELEASE) | Resolved | 2017-03-17 | 2017-09-19 | 3377 |
| ACT OXYCODONE CR | 20MG | TABLET (EXTENDED-RELEASE) | Resolved | 2017-03-17 | 2017-07-01 | 3381 |
| ACT OXYCODONE CR | 80MG | TABLET (EXTENDED-RELEASE) | Resolved | 2017-03-17 | 2017-09-19 | 3384 |
| ACT OXYCODONE CR | 40MG | TABLET (EXTENDED-RELEASE) | Resolved | 2017-05-24 | 2017-09-19 | 10978 |
| ACT PIOGLITAZONE | 45MG | TABLET | Resolved | 2020-03-12 | 2022-04-21 | 108625 |
| ACT PIOGLITAZONE | 15MG | TABLET | Resolved | 2021-04-21 | 2022-04-28 | 137882 |
| ACT PIOGLITAZONE | 30MG | TABLET | Resolved | 2021-04-21 | 2022-04-28 | 137905 |
| ACT PIOGLITAZONE | 45MG | TABLET | Resolved | 2024-01-18 | 2025-01-15 | 216454 |
| ACT PIOGLITAZONE | 15MG | TABLET | Resolved | 2024-05-09 | 2025-01-15 | 227483 |
| ACT PIOGLITAZONE | 30MG | TABLET | Resolved | 2024-05-09 | 2025-01-15 | 227486 |
| ACT PIOGLITAZONE | 15MG | TABLET | Actual shortage | 2025-08-08 | 2025-10-02 | 264798 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-VALSARTAN | 40MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258501 |
| TEVA-VALSARTAN/HCTZ | 12.5MG 80MG | TABLET | Discontinued | 2025-04-25 | 2025-04-25 | 255827 |
| TEVA-VALSARTAN/HCTZ | 12.5MG 160MG | TABLET | Discontinued | 2025-04-25 | 2025-04-25 | 255830 |
| TEVA-VALSARTAN/HCTZ | 25MG 160MG | TABLET | Discontinued | 2025-04-25 | 2025-04-25 | 255833 |
| TEVA-VALSARTAN/HCTZ | 12.5MG 320MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256140 |
| TEVA-VALSARTAN/HCTZ | 25MG 320MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256143 |
| TEVA-VENLAFAXINE XR | 75MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-02-07 | 2020-02-08 | 105537 |
| TEVA-VENLAFAXINE XR | 37.5MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-06-11 | 2020-06-11 | 117546 |
| TEVA-VENLAFAXINE XR | 150MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-09-24 | 2020-09-24 | 124899 |
| TEVA-VORICONAZOLE | 200MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256166 |
| TEVA-VORICONAZOLE | 50MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256169 |
| VINORELBINE TARTRATE FOR INJECTION | 10MG | SOLUTION | Discontinued | 2019-09-27 | 2019-10-01 | 94980 |
| VINORELBINE TARTRATE FOR INJECTION | 10MG | SOLUTION | Discontinued | 2019-10-17 | 2019-10-17 | 96695 |
| ZOLEDRONIC ACID FOR INJECTION | 4MG | SOLUTION | Discontinued | 2025-05-28 | 2025-05-28 | 258583 |
| ZOLEDRONIC ACID INJECTION | 5MG | SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14030 |